Abstract
The significance of primary tumor resection in gastric and colorectal cancer patients with liver metastasis (H(+)) was evaluated in terms of operative mortality and survival rate by dividing the materials [293 gastric cancer and 80 colorectal cancer patients (53 colon and 27 rectum) with synchronous liver metastasis] into the following groups: Firstly, with or without peritoneal dissemination (P), secondly, with or without resection of the primary tumor and thirdly, with or without postoperative adjuvant chemotherapy. The following results were obtained: (1) The direct operative death rate of primary tumor resection, excluding death from other causes, showed an absence of statistically significant differences between the P0H(+) and P(+)H(+) gastric and colorectal cancer patients. (2) There was no significance in the prognosis between the primary tumor resection + postoperative chemotherapy group and the non-resectable group in the P(+)H(+) gastric and colorectal cancer patients, revealing no prognostic value of the primary tumor. (3) In the P0H(+) gastric and colorectal cancer patients, the primary tumor resection + postoperative chemotherapy group was significantly more favorable in prognosis than was the primary tumor resection alone group or the non-resectable group, showing the value of primary tumor resection.
Similar content being viewed by others
References
Jaffe BM, Donegan WL, Watson F, Spratt JS. Factors influencing survival in patients with untreated hepatic metastases. Surg Gynecol Obste 1968; 127: 1–11.
Bengmark S, Hafstrom L. The natural course for liver cancer. Prog Clin Cancer 1978; 7: 195–200.
Okuyama K, Isono K, Juan I, Onoda S, Ochiai T, Yamamoto Y, Koide Y, Satoh H. Evaluation of treatment for gastric cancer with liver metastasis. Cancer 1985; 55: 2498–2505.
Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery and pathology. Jpn J Surg 1981; 1: 127–145.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 459–481.
Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163–170.
Yonemura Y, Miyazaki I. Treatment of advanced gastric cancers with liver metastasis. Shokaki Geka Gastroenterological Surgery 1986; 9: 1737–1747. (in Japanese)
Ito I, Hattori T, Koyama Y, Ooboshi S, Fujita H: Chemotherapy of the primary and metastatic hepatic cancer by hepatic arterial infusion. Gan no Rinsho Jpn J Cancer Clin 1964; 10: 412–423. (in Japanese).
Hoshino T. Evaluation of palliative operation for gastric cancer. Gan no Rinsho Jpn. J Cancer Clin 1958; 4: 423–431. (in Japanese)
Ohta H, Takagi K. Studies on liver metastasis for carcinoma of the stomach. Shokaki Geka Gastroenterological Surgery 1981; 4: 999–1004. (in Japanese)
Shahon DB. Cancer of the stomach; Analysis of 1152 cases. Surgery 1956; 39: 204–221.
Lawrence W. The effectiveness of surgery for palliation of incurable gastric cancer. Cancer 1958; 11: 28–32.
Fujimoto S, Miyazaki M, Okui K. Anticancer treatment for synchronous hepatic metastasis from stomach cancer. J Jpn Soc Cancer Ther 1982; 17: 1864–1872.
Nakae S, Nakamura T, Inoue K, Katoh M, Saitoh Y. Treatment for gastric cancer patients with synchronous liver metastasis. Nippon Shokaki Geka Gakkai Zasshi The Japanese Journal of Gastroenterological Surgery 1986; 19: 2341–2347 (in Japanese)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Okuyama, K., Onoda, S., Tohnosu, N. et al. The prognostic significance of resection of primary tumor in gastric and colorectal cancer patients with synchronous liver metastasis. The Japanese Journal of Surgery 18, 7–17 (1988). https://doi.org/10.1007/BF02470840
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02470840